Telangana: Aurobindo Pharma has announced that the Company will be investing Rs.10.40 crores to acquire 26 percent equity and ...

In a recent transaction, Peter Altman, President and CEO of BioCardia, Inc. (NASDAQ:BCDA), purchased 600 shares of the company's common stock. The shares were acquired at an average price of $2.48 per ...

BioCardia, Inc. (NASDAQ:BCDA), a micro-cap biotech company with a market value of $11.4 million, saw its President and CEO ...

Japanese Prime Minister Shigeru Ishiba's cabinet approval rate rose 5 points from the previous month to 44% in a February 7-9 ...

Japan's Cabinet approved amendments to the Act on the Promotion of Information Processing and the Act on Special Accounts on ...

Bain Capital said the deal came about following several recent initiatives by the Japanese government and regulators to ...

If approved, ACP has the potential to become the first and only GA treatment available in Japan. GA is a progressive form of AMD that can cause irreversible vision loss, with no treatments currently ...

Private equity firm Bain Capital (BCSF) is paying $3.4 billion to buy a 350-year-old Japanese drugs group fighting diabetes ...

His deportation policy finds majority approval overall — just as most voters said they wanted during the campaign — and that extends to sending troops to the border, too. But one key issue ...

Kisunla (donanemab) is the second in a new generation of amyloid-targeting medicines to reach the Japanese market after Eisai and Biogen's Leqembi (lecanemab), which was approved by the country's ...

Japan approved a 39 trillion yen ($250 billion) economic stimulus package Friday centered around initiatives it said were aimed at boosting individual incomes. The broad plan passed by the Cabinet ...

Daiichi Sankyo has made a little bit of pharma industry history, becoming the first drugmaker to win approval in Japan for a therapy for cancer based on a virus that selectively kills malignant cells.